Understanding Opioids A primer in MAT, detox, overdose, and prevention
|
|
- Darlene Johnston
- 5 years ago
- Views:
Transcription
1 Understanding Opioids A primer in MAT, detox, overdose, and prevention 9/9/2016 Robert Levy MD, University of Minnesota North Memorial Medical Center Wi-fi Information: NETWORK: EC-CTR PASSWORD: westgate252 Add Event Logo if exists Disclosure Robert Levy reports no actual or potential conflicts of interest associated with this presentation. 1
2 Learning Objectives Upon successful completion of this activity, pharmacists should be able to: 1. Learn how to identify withdrawal and triage it's severity 2. Understand that substance use disorder is a brain disease with behavioral elements 3. Understand Medication Assisted Therapy (MAT) basics and the different modes and legal issues that arise. 4. Know and learn to apply best practices for withdrawal from opioids and to a lesser extent benzodiazepines and alcohol, including warning signs of severe disease Deaths Overdose Pain Prescriptions Deaths Center for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, Mortality File. (2015). Number and Age-Adjusted Rates of Drug-poisoning Deaths Involving Opioid Analgesics and Heroin: United States, Atlanta, GA: Center for Disease Control and Prevention. Available at AADR_drug_poisoning_involving_OA_Heroin_US_ pdf. 2
3 Overdose Deaths Pain Prescriptions Heroin Overdose Death Rates Parallel Sales of Pain Prescriptions > x increase in rate of overdose deaths related to prescriptions pain pills > x increase in sales of prescription pain pills Paulozzi MD, Jones PharmD, Mack PhD, Rudd MSPH. Vital Signs: Overdoses of Prescription Opioid Pain Relievers United State, Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Center for Disease Control and Prevention. 2011:60: Million opioid Prescriptions 2012 Enough for every adult in the U.S. to have one bottle Centers for Disease Control and Prevention. (2014). Opioid Painkiller Prescribing, Where You Live Makes a Difference. Atlanta, GA: Centers for Disease Control and Prevention. Available at 3
4 Opioid Prescriptions and Heroin Use 4 of 5 heroin users started out misusing prescription pain pills Hedegaard MD MSPH, Chen MS PhD, Warner PhD. Drug-Poisoning Deaths Involving Heroin: United States, National Center for Health Statistics Data Brief. 2015:190:1-8. Addiction (SUD) as a disease Myths: Moral Failing Trauma in Childhood Poverty Lack of Education Truth It s a chronic relapsing disease No History of Drug Use Risk Genotypes Unknown Ini,a,on of Use Genetic Factors Regular Use Addic,on/Dependence Environmental Factors Relapse Recovery Death 4
5 ASAM Long Definition of Addiction Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry. The neurobiology of addiction encompasses more than the neurochemistry of reward. Genetic factors account for about half of the likelihood that an individual will develop addiction. Other factors that can contribute to the appearance of addiction, leading to its characteristic bio-psycho-socio-spiritual manifestations. Addiction is characterized by an inability to abstain, impairment in behavioral control, craving, diminished recognition of associated problems, and a dysfunctional emotional response. ASAM August 15, 2011 Koob definition Addiction is a chronic relapsing syndrome that moves from an impulse control disorder involving positive reinforcement to a compulsive disorder involving negative reinforcement. Establishment of Addiction 1) Many of the patterns of addiction are related to the reward system. 2) The reward system is modulated by dopamine. 3) Models illustrate that animals will self administer a drug or electrical stimulation in order to maintain dopamine levels in the nucleus accumbens 5
6 Most Drugs of Abuse Affect Dopamine Drug Characteristics Very few chemicals (about 322 out of 34 million in CAS) are addicting Fairly broad range of chemical structures d-amphetamine diacetylmorphine striatum caudate putamen cingulate cortex medial orbitofrontal cortex amygdala hippocampus parahipocampus prefrontal cortex mesostriatal mesolimbic mesocortical Thalamus Nucleus Accumbens ABN VTA 6
7 Frontal Cortex Acc Amygdala Amphetamine Cocaine Opioids Cannabinoids Phencyclidine Ketamine VTA VP ABN Median Forebrain Bundle Opioids Ethanol Benzodiazepines Barbiturates Nicotine Cannabinoids Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci Sep;14(9): doi: /nrn3381. Addiction leads to impaired learning and impaired function of the frontal cortex Addiction affects the previous functions: 1. Value of the reward is overestimated. 2. Negative consequences are not recognized. 3. Summed risk/benefit decisions are biased in the direction of continued substance abuse. 4. Drive states are reprioritized. Fuster JM. The Prefrontal Cortex, 4 th ed. Addiction. London, Academic Press,
8 So Addiction is a disease but how did we get here? Rich history of addiction in the US International Opium Convention Before: Tonics Treatment for alcoholism Hypodermic Needle and Morphine American civil war History of prescribed opioids Heroin Bayer Demerol Farben Oxycodone Purdue Tramadol Watson Many others Pressure to Prescribe Pain as the 5 th vital sign Patient Satisfaction scores and $$$ Porter and Jick JAMA in
9 Medical Providers as Source of the Problem Physician s Dilemma Direct Marketing Pressure to prescribe 259 Million opioid Prescriptions 2012 Enough for every adult in the U.S. to have one bottle Centers for Disease Control and Prevention. (2014). Opioid Painkiller Prescribing, Where You Live Makes a Difference. Atlanta, GA: Centers for Disease Control and Prevention. Available at Physicians Quandary About Pain and Addiction We have little training in addiction We have little training in pain. Yet pain is the most common reason for a primary care visit, and addiction is one of the most common illnesses seen in primary care. 9
10 Lack of Education and Pressure Data varies but 50% diversion Valuable and pure Oxycontin switch Increase in price Rise of Heroin & Cartels Drug Trafficing influence Poppies difficult to grow Super labs Meth Fentanyl Carfentanil Krokodil Risks of OD Dose of opioids VA study Follow-up analysis Long vs. short acting Other factors Role of Naloxone 10
11 Overdose Risk and Opioid Dose Percent of Person Years Opioid Dosage (mg/d) Percent Use Odds Ratio Narcan Who Benefits? In short, anyone with a history of opioid IV use Any patient on more than 100mg equivalents of Morphine daily Anyone with a history of opioid overdose Patients on 50-99mg equivalents of Morphine daily and a benzo or benzo like sleeping medication How to Distribute Narcan Comes in three forms IM injection Auto-injector Costly Intranasal Kits Difficult to find Equally effective Consider ease of use and cost Don t forget about ½ life! 11
12 Recognition of intoxication Mild - Moderate Apathy, dysphoria or euphoria, psychomotor retardation, drowsiness, dysarthria, impaired attention, pinpoint pupils Severe Respiratory depression Bradycardia Stupor or Coma Opioid Withdrawal Not lethal right??? Jean L How to recognize it? Opioid Withdrawal Diagnose via Clinical Opioid Withdrawal Scale (COWS) Timeline depends on the opioid of abuse Mild Dysphoric mood -N/V Muscle aches - Lacrimation or rhinorrhea Pupillary dilation - Piloerection or sweating Diarrhea/yawning - Insomnia Moderate to severe Hypertension - Tachycardia Seizures (especially Tramadol) Fever 12
13 COWS Graded on a 1-4(5) scale Resting pulse rate - Restlessness GI upset - Yawning Sweating - Pupil size Tremor - Anxiety or irritability Bone or joint aches - Gooseflesh skin Runny nose or tearing Score 5-12=mild =moderate 25-36=moderately severe More than 36=severe withdrawal COWS vs. CIWA Many similarities make it difficult to determine alcohol vs. opioid withdrawal CIWA Visual, auditory, tactile disturbances is specific Much more headache and headfullness COWS Bone or joint aches - Gooseflesh skin Runny nose or tearing - Pupil size Yawning Opioid Withdrawal Treatment Why treat at all? Goals of treatment Risk of relapse & Death Changes in tolerance 13
14 Glutamate GABA System GABA Glutamate- NMDA + AMPA receptors Inhibition Excitation Unopposed excitation Chronic Use Opioid Withdrawal Treatment Comfort medications Naproxen for pain Hydroxyzine for anxiety Trazadone for sleep Dicyclomine for abdominal pain Methocarbamol for muscle spasms Clonidine for agitation Gabapentin for restless legs Substitution treatment Remember it is actually illegal to prescribe opioids for opioid withdrawal (well it s a grey area ) Buprenorphine Methadone 14
15 Buprenorphine Pain medication first Partial agonist DATA 2000 Waiver DEA vs FDA Legal and on label to use for withdrawal and pain Buprenorphine Suboxone vs Buprenorphine Naloxone Does it work? Different formulations Different routes SL vs. IM vs. IV Methadone First synthesized in German in 1939 Many drug-drug interactions Long half life Stacking QTc Many legal loop holes Only time can be perscribed out of clinic is known as the three day rule 15
16 What Happens After Withdrawal? Modalities of treatment for opioid dependence are many and outcome data is lacking Project Match Large national study funded by NIAAA Outpatient: 9 sites, N = 1726 Compared three methods Motivational Enhancement Cognitive Behavioral Twelve Step Facilitation Project Match variables Wide range of matching variables demographics severity personality Numerous outcome points and variables percent of drinking days drinks per drinking day 16
17 Project MATCH 1-year outcomes Few significant differences between the three treatments Can this even be extrapolated to opioid dependence? What about long term substitution treatment? agent action Agonist - Methadone receptor Partial Agonist Buprenorphine Antagonist - Naltrexone x 17
18 Phase 1 2 wk Bup/Nal, 2 wk taper, 8 wk f-up Phase 2 Phase 1 pts who relapsed - 12 wk Bup/Nal, 4 wk taper, 8 wk f-up Outcomes % no opioid use P value Phase 1 -end 7.4%.36 Phase 2 -end Rx Phase 2-8 wk f- up End Rx vs 8wk f- up <.001 Weiss et al. Arch Gen Psych 2011 Role of Naltrexone - Randomized, doubleblind, placebocontrolled, 24 wk trial opioid-dependent adults % Abstinent mg SR naltrexone every 4 wks. - Liver enzyme elevation in SR Naltrexone group but no diff. in discontinuation. 0 Placebo Naltrexone Cravings Placebo Naltrexone Krupitsky et al. Lancet 377: 1506, Krupitsky et al. Lancet
19 Management of pain on Naltrexone Oral naltrexone half-life 14 hrs. Stop hrs before elective procedure. Sustained- release naltrexone 28 day duration of action 1. Non - opioid analgesics 2. Regional nerve block 5. Consult Addiction specialist 3. Ketamine? Clonidine? Precedex? 4. Careful reversal with high-dose opioids - consult anesthesiologist - airway monitoring - opioid tolerance hard to predict Different Schools of Thought Harm Reduction vs. Abstinence treatment AA/NA vs MAT Head to head studies difficult and basically nonexistent Psychodynamic/CBT/DBT/TFT Inpatient treatment vs. outpatient Desperate Measures: Ibogaine First commonly advertised as having antiaddictive properties in Howard Lotsof Illegal in the US Thailand/Africa tribal settings Some research backs this up sigma-2 and nicotinic receptors 19
20 Chronic Pain and Addiction Large overlap clinically Chicken or the egg problem Pressure to treat patient satisfaction Altered Neuro Structure Chronic pain accompanied by cortical reorganization: Flor, Neurosci Lett, 1997 Chronic back pain is accompanied by brain atrophy: Apkarian, Neurosci, 2004 New Research Latest ASAM conference Dr. Ebkari Cronification of pain Chronic pain maladaptation occurs mostly in the limbic system Particularly the Nucleus Accumbens Some brain changes similar to that of chemical dependency Chronic, likely life long, disease model. 20
21 Tools To Screen For Substance Use Disorders (SAMHSA TIP 54, Exhibit 2-8) Tool Alcohol, Smoking, and Substance Involvement Screening Test Alcohol Use Disorders Identification Test (AUDIT) Format 1 item for lifetime use, 6 items for each of 10 sub-stances used, and 1 item on injection use 10-item screening questionnaire Administration/ Scoring Time Depends on number of substances used 2 minutes to administer/ 1 minute to score AUDIT-C 3-item screening questionnaire Less than 1 minute to administer and score CAGE Adapted To Include Drugs 4 yes/no questions Less than 1 minute/ not scored Drug Abuse Screening Test 20 yes/no questions 1 2 minutes to administer/ not scored Michigan Alcoholism Screening Test (MAST) (MAST-G for older adults) 24 yes/no questions 10 minutes to administer/ 5 minutes to score Training Required Yes Yes Yes No No No Aberrant Drug-Related Behaviors More Predictive Selling prescription drugs Prescription forgery Stealing or borrowing drugs from another patient Injecting oral formulations Less Predictive Aggressive complaining about the need for higher doses Drug hoarding during periods of reduced symptoms Requesting specific drugs Prescriptions from other physicians Obtaining prescription drugs from non-medical sources Unsanctioned dose escalation Concurrent abuse of related illicit drugs Multiple, unsanctioned dose escalations Repeated episodes of lost prescriptions Unapproved use of a drug Reporting psychic effects not intended by the physician Portenoy 1996 Role of Treatment Chronic pain and Addiction also share similar treatment modalities CBT/DBT found to be helpful Opioids Induced hyperalgesia 21
22 Co-Occurring Mental Health Depression/Anxiety ADHD Suicidal ideation Suicide Attempts Most dangerous time is right after intervention or detection AAAP vs. ASAM Role of pharmacotherapy Addicted Health Care Professionals Pharmacists/Physicians are no different Sorry Rate 22
23 Epidemiology The reasons for higher rates of opioid and benzodiazepine substance use disorders among physicians and nurses are multi-factorial Easier access Frequently used in line of work Stressful work environment Personality factors (perfectionism) Feelings of omnipotence (invulnerable to illness) Intellectualization (TMI) Evaluation and Treatment Occupation (January-July 2012) HCPs: Differences in Outcomes Success rates are disputed, but most agree that outcomes are excellent in >80% of physicians treated Five-year sustained abstinence rates (rated as a good outcome ) range from 75-92% compared to <50% at one year in the general population ~25% of physicians have at least one relapse 74% of those had only one episode of alcohol or drug use Outcomes are less impressive for nurses due to multiple factors (eg, less intense treatment, financial barriers, licensure problems, less aftercare support) Still unclear about the persistence of these outcomes 23
24 Summary Addiction is a chronic disease We are in the middle of a crisis Overdose is predictable and preventable Withdrawal can kill Treatment works No one is immune Questions? Robert Levy MD Levyx114@umn.edu 24
Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?
Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives
More informationOpioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine
Natural derivatives of opium poppy - Opium - Morphine - Codeine Opioid Agonists Semi synthetics: Derived from chemicals in opium -Diacetylmorphine Heroin - Hydromorphone Synthetics - Oxycodone Propoxyphene
More informationOpioids. Sergio Hernandez, MD
Opioids Sergio Hernandez, MD Required Slide Disclosures 1. SIGNIFICANT FINANCIAL INTERESTS NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT 2. GENERAL AND OBLIGATION INTERESTS All general
More informationMedication-Assisted Treatment. What Is It and Why Do We Use It?
Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationMain Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
More informationBuprenorphine Prescribing as a Patient- Centered Medical Home Enhancement
Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement TANNER NISSLY DO, BOB LEVY MD FASAM, MICHELE MANDRICH MSW, CMPE AS YOU ENTER, PLEASE SET UP TO PARTICIPATE IN OUR POLL EVERYWHERE
More informationOpioids Research to Practice
Opioids Research to Practice May 2013 Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Assistant Dean, Continuing Medical Education Case 32 yo female brought in after heroin overdose
More informationOpioids Research to Practice
Opioids Research to Practice CRIT/FIT 2016 April 2016 Daniel P. Alford, MD, MPH Associate Professor of Medicine Assistant Dean, Continuing Medical Education Director, Clinical Addiction Research and Education
More informationPrescription Opioid Addiction
CSAM-SCAM Fundamentals Prescription Opioid Addiction Presentation provided by Meldon Kahan, MD Family & Community Medicine University of Toronto Conflict of interest statement I received funds from Rickett
More informationAddiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer
Addiction to Opioids Marvin D. Seppala, MD Chief Medical Officer Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice Friday, September 30, 2016 26 y.o. female from South
More informationAnalgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015
Analgesia for Patients with Substance Abuse Disorders Lisa Jennings CN November 2015 Definitions n Addiction: A pattern of drug use characterised by aberrant drug-taking behaviours & the compulsive use
More informationWithdrawal.
Withdrawal Shamim Nejad, MD Director, Adult Burns & Trauma Psychiatry Division of Psychiatry and Medicine Medical Director, Addiction Consultation Team MGH Center for Addiction Medicine Massachusetts General
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2008 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationTreatment Alternatives for Substance Use Disorders
Treatment Alternatives for Substance Use Disorders Dean Drosnes, MD, FASAM Associate Medical Director Director, Chronic Pain and SUD Program Caron Treatment Centers 1 Disclosure The speaker has no conflict
More informationSubstance Use and Mental Health Disorders: Challenges for Primary Care
Substance Use and Mental Health Disorders: Challenges for Primary Care Ted Parran MD FACP Carter and Isabel Wang Professor of Medical Education CWRU School of Medicine tvp@cwru.edu Euphoria Producing Drugs
More informationOverview of Opioid Use Disorder
Overview of Opioid Use Disorder Doug Burgess, MD Medical Director of Outpatient Services, Truman Medical Centers Assistant Professor of Psychiatry, University of Missouri- Kansas City Objectives History
More informationOpioids. October 29, Addiction Medicine Review Course CSAM, Newport Beach, CA
Opioids October 29, 2010 Addiction Medicine Review Course CSAM, Newport Beach, CA Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Boston University School of Medicine Boston Medical
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2010 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationPrescription Opioids
What are prescription opioids? Prescription Opioids Opioids are a class of drugs naturally found in the opium poppy plant. Some prescription opioids are made from the plant directly, and others are made
More informationOpioid dependence: Detoxification
Opioid dependence: Detoxification What is detoxification? A. Process of removal of toxins from the body? B. Admitting a drug dependent person in a hospital and giving him nutrition? C. Stopping drug use
More informationMedication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs
Medication Assisted Treatment Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Disclosures Employed by the Department of Veterans Affairs
More informationOpioid Overdose Epidemic A Crises and Opportunity
Opioid Overdose Epidemic A Crises and Opportunity Samuel M. Silverman MD, FAPA, DFASAM Assistant Clinical Professor, UConn Medical School Director, Medical Education Rushford, A Hartford HealthCare Partner
More informationWasted AN INTRODUCTION TO SUBSTANCE ABUSE
Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING
More informationDeveloped and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services
Developed and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services www.randallwebber.com MAT clients are still addicted Truth: MAT clients will experience withdrawal symptoms if they stop
More informationArwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry
The State of Medicine in Addiction Recovery Arwen Podesta, MD ABIHM, ABAM, Forensic Psychiatry www.podestawellness.com 504-252-0026 http://www.addictionpolicy.org/ Overview Addiction is a serious, chronic
More informationOpiate Use Disorder and Opiate Overdose
Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5
More informationGOALS AND OBJECTIVES
SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationMANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners Grand Rounds October 11, 2017 Disclosures One
More informationSW OREGON OPIOID SUMMIT. Medication Assisted Recovery for Opioid Use Disorder. Gregory S. Brigham, Ph.D. Adapt / SouthRiver CHC / Compass
SW OREGON OPIOID SUMMIT Medication Assisted Recovery for Opioid Use Disorder Gregory S. Brigham, Ph.D. Adapt / SouthRiver CHC / Compass Opioid Agonists Mu (μ) receptors stimulated by opioids causing full
More informationWhat do they have in common?
What do they have in common? Opioid use in USA Approximately 9 million people on long term opioids Approximated 5 million people reporting non-medical use of opioids 1997: 96mg/person morphine eq dispensed
More informationModule II Opioids 101 Opiate Opioid
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module II Opioids 101 Module II Goals of the Module This module reviews the following:! Opioid addiction and the brain!
More informationStrategies to Manage The Opioid Crisis
Strategies to Manage The Opioid Crisis Matt Feehery, LCDC Senior Vice President & CEO PaRC (Prevention & Recovery Center) Behavioral Health Services February 1, 2018 A Pill for Your Pain But my doctor
More informationMedication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment
Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin
More informationAddressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain
Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain Ajay D. Wasan, MD, MSc Professor of Anesthesiology and Psychiatry Vice Chair for Pain Medicine, Department of Anesthesiology University
More information8/28/2017. Headlines. How Did We Get Here? Pain is the number one reason patients go the doctors office, urgent care and/or emergency room.
Ashel Kruetzkamp, MSN, RN, SANE Headlines How Did We Get Here? Pain is the number one reason patients go the doctors office, urgent care and/or emergency room. Opiates are the most effective pain medication
More informationThe Substance Abuse Epidemic and the Essential Role for the Family Physician
The Substance Abuse Epidemic and the Essential Role for the Family Physician Joseph Garbely, D.O., FASAM Medical Director VP of Medical Services 1 ASAM Disclosure of Relevant Financial Relationships No
More informationTopics of today s training
Extended Release Naltrexone Vivitrol Christopher J Davis D.O. CAADC, FASAM Medical Director, Brightwater Landing Medical Director, Pyramid Healthcare Diplomate of The American Board of Addition Medicine
More informationAdmit date: 1-WM 2-WM 3.2-WM 3.7-WM 4-WM DSM-V diagnoses: Please list all diagnoses (psychiatric, chemical dependency and medical)
https://providers.amerigroup.com Substance Use Disorder Withdrawal Management Prior Authorization and Continued Care Request (Use for American Society of Addiction Medicine [ASAM] withdrawal management
More informationAddiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017
Addiction Overview Causes Consequences Treatments Methadone/Buprenorphine 101 April 1, 2017 Diane A. Rothon MD Why? would you listen to this presentation Review the definition and neurobiology of addiction
More informationCharles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus
Pain & Opioid Epidemic 2018 Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus Opioids 3400 BC Mesopotamia, Joy plant 1843 morphine by syringe 1874
More informationten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment
ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment This booklet was created to help you learn about tapering. You probably have lots
More information2/21/2018. What are Opioids?
Opioid Crisis: South Carolina Responds Carolyn Bogdon, MSN, FNP-BC Coordinator for Emergency Department Medication Assisted Treatment Program Medical University of South Carolina Opioid Crisis: A Mounting
More informationMedicated Assisted Treatment
Medicated Assisted Treatment Enhancing the Potential for Recovery Part I Diana Padilla Program Manager NeC-ATTC 2 Diana Padilla, RCR, CASAC-T padilla@ndri.org Diana Padilla is a program manager at NDRI-USA,
More informationTake Home Naloxone elearning Module Script
elearning Module Script Slide 1-3 Review the outline and the plan for the presentation. Slide 4 We do accept the cynicism of this poster. Slide 5 Read from the slide the definition of Harm Reduction Slide
More informationOpioid Epidemic Update
Opioid Epidemic Update - 2018 Talal Khan MD Addiction Psychiatrist Pine Rest What are Opioids? Opiates are alkaloid compounds naturally found in the opium Poppy plant. Papaver somniferum The psychoactive
More informationROSC & MAT II: Opioid Treatment Services
ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify
More informationPAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)
Pain - subjective experience associated with detection of tissue damage ( nociception ) acute - serves as a warning chronic - nociception gone bad often accompanied by clinical depression fibromyalgia,
More informationThe Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower.
The Opiate Crisis Presented by Dr. Anahi Ortiz Franklin County Coroner April 9, 2018 Words are important. If you want to care for something, you call it a flower. If you want to kill something, you call
More informationPrepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry
Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over
More informationThe Opioid Epidemic and Youth Prescription Drug Abuse. Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth
The Opioid Epidemic and Youth Prescription Drug Abuse Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth Disclosures: I have no relevant financial relationships with the manufacturer(s)
More informationOpioid dependence and buprenorphine treatment
Opioid dependence and buprenorphine treatment David Roll, MD Revere Family Health, Cambridge Health Alliance Instructor in Medicine, Harvard Medical School Joji Suzuki MD Medical Director of Addictions
More informationDiscover the Hope: Opiate Treatment and Recovery
Discover the Hope: Opiate Treatment and Recovery The Continued Struggle to Find and Implement Best Practices Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of
More informationUnderstanding Addiction: Why Can t Those Affected Just Say No?
Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions
More informationChapter 7. Screening and Assessment
Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions
More informationAn overview of Medication Assisted Treatment (MAT) and acute pain management on MAT
An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT Goals of Discussion Recognize opioid use disorder (OUD) Discuss the pharmacology of medication assisted treatments (MAT)
More informationMedication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.
Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction
More informationKen Roy, MD, FASAM. The Opioid Epidemic and Addiction Involving the Use of Opioids. Tulane & LSU Department of Psychiatry
Ken Roy, MD, FASAM The Opioid Epidemic and Addiction Involving the Use of Opioids Addiction Recovery Resources, Inc. Tulane & LSU Department of Psychiatry www.arrno.com kenroymd@cox.net CDC Guidelines
More informationWhat Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016
What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)
More informationOpioid Use Disorders &Medication Treatment
Agency medical director comments Opioid Use Disorders &Medication Treatment Charissa Fotinos, MD, MSc Deputy Chief Medical Officer Washington State Health Care Authority Learning Objectives: 1) Review
More informationMedication Assisted Treatment. Michael Palladini, RPh MBA CAC
Medication Assisted Treatment Michael Palladini, RPh MBA CAC palladini.michael@gmail.com History of MAT Addiction as a Disease The concept of addiction as a disease of the brain challenges deeply ingrained
More informationSAFE PRESCRIBING: RULES AND REGULATIONS. Michelle Y. Owens, MD MS State Board of Medical Licensure June 30, 2017
SAFE PRESCRIBING: RULES AND REGULATIONS Michelle Y. Owens, MD MS State Board of Medical Licensure June 30, 2017 DISCLOSURES I have no financial disclosures. OBJECTIVES Discuss the significance of the opiate
More informationBuprenorphine for Family Medicine. Hannah Snyder, MD Addiction Medicine Fellow, UCSF 12/7/17
+ Buprenorphine for Family Medicine Hannah Snyder, MD Addiction Medicine Fellow, UCSF 12/7/17 + Disclosures No conflicts of interest Off-label use of medications + Who here: Has taken care of a patient
More informationTHE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.
THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.
More informationOpioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue
Opioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue Scope Pharmacology of Opioids Equivalence Dependence and Withdrawal Methadone Maintenance (OST) 3 Opioid
More informationAmerica is a drugged society
Overview of Drug Abuse Basic Considerations. M. Imad Damaj, Ph.D. Associate Professor Dept. of Pharmacology/Toxicology, Virginia Commonwealth University America is a drugged society 90% of all drugs manufactured
More informationAnyone Can Become Addicted. Anyone.
Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.
More informationChronic Pain, Opioids, & Addiction: Assessing and Managing Risk
Chronic Pain, Opioids, & Addiction: Assessing and Managing Risk Randy Brown MD, PhD, FASAM Associate Professor, Dept of Family Medicine Director, Center for Addictive Disorders, UWHC Director, UW Addiction
More informationTapering Opioids Best Practices*
Tapering Opioids Best Practices* Chuck Hofmann, MD, MACP 5 th Annual EOCCO Office Staff and Provider Summit September 28, 2017 Disclosure No Conflicts of Interest to report Learning Objectives Understand
More informationSubstance Use Disorders. A Major Problem. Defining Addiction 2/24/2009. Lifetime rates of alcoholism estimated at 13.4 %
Substance Use Disorders A Major Problem Lifetime rates of alcoholism estimated at 13.4 % Rates of drug abuse estimated at 6% Marijuana is most frequent Approximately 600,000 deaths each year from substance
More informationSubstitution Therapy for Opioid Use Disorder The Role of Suboxone
Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM
More informationThe Neurobiology of Addiction
The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly
More informationOpioid Initiative Wave I Treating Opioid-Use Disorder in the ED Part 1
Opioid Initiative Wave I Treating Opioid-Use Disorder in the ED Part 1 Presenter Eric Ketcham, MD, MBA Reuben J. Strayer, MD emergency department management of the patient with opioid withdrawal OD is
More informationMedication Assisted Treatment for Opioid Use Disorders and Veteran Populations
Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations Kamala Greene Genece, Ph.D. VP, Clinical Director Phoenix Houses of New York Benjamin R. Nordstrom, M.D., Ph.D. President
More informationPSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH
PSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH OVERVIEW: PSYCHIATRIC DISORDERS Mood Disorders Anxiety Disorders Psychotic Disorders Personality Disorders PTSD Eating Disorders EXAMPLE What is the diagnosis?
More informationDISCLOSURES MANAGEMENT OF OPIOID USE DISORDERS LECTURE COVERS. SUDs ARE IMPORTANT. I have nothing to declare
MANAGEMENT OF OPIOID USE DISORDERS DISCLOSURES Marc A Schuckit Distinguished Professor of Psychiatry, UCSD Medical School I have nothing to declare SUDs ARE IMPORTANT Affect > 20% of your patients Are
More informationOpioid Use in Youth. Amy Yule M.D. March 2,
Opioid Use in Youth Amy Yule M.D. March 2, 2018 An opioid is a substance that acts on opioid receptors Beta-endorphin Endogenous opioids Dynorphin Opiates Natural products of the poppy plant Morphine Heroin
More informationMEDICATION ASSISTED TREATMENT
MEDICATION ASSISTED TREATMENT MODULE 14 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER Medication Assisted Treatment Types of Medication Assisted Treatment: Methadone Naltrexone
More informationMayors Opioid Summit PATTERNS AND TRENDS OF THE OPIOID EPIDEMIC IN BROWARD COUNTY TYPES OF OPIOIDS DEFINITION OF OPIOID. Pill Press from China
The Opioid Epidemic In Broward County 8/24/217 Mayors Opioid Summit PATTERNS AND TRENDS OF THE OPIOID EPIDEMIC IN BROWARD COUNTY Jim Hall Senior Epidemiologist Center for Applied Research on Substance
More informationArizona s Opioid Epidemic
Arizona s Opioid Epidemic Rise in Heroin Addiction and the Dangers of Fentanyl Sara Salek, MD Chief Medical Officer Shana Malone, MS Clinical Initiatives Project Manager 1 Disclosures None The National
More information8/5/2013. MOSBIRT Annual Training The Big change in addiction medicine? Before we dive into pharmacotherapy
Medication Assisted Treatment for Substance Abuse in Primary Care Dan Vinson August 1, 2013 1 The Big change in addiction medicine? These diseases are rapidly becoming medical diseases. Done are the days
More informationMary Ann Ferguson,Pharmacist St Josephs Health Care Concurrent Disorders Inpatient Unit
Mary Ann Ferguson,Pharmacist St Josephs Health Care Concurrent Disorders Inpatient Unit Fergusom@stjoes.ca Medication should be considered as part of the treatment plan for addictions/substance use disorders:
More informationAcademic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD
Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction
More information3/26/14. Opiates PSY B396 ALCOHOL, ALCOHOLISM, & DRUG ABUSE. Early History Cont d. Early History. Opiate Use in the 19th century. Technology Advances
Opiates PSY B396 ALCOHOL, ALCOHOLISM, & DRUG ABUSE Chapter 10 Opiates The most dramatic example of the doubleedged sword character of drugs Most potent painkillers Prototype addictive drug: Heroin Early
More informationControlled Substance and Wellness Agreement
Controlled Substance and Wellness Agreement You and your provider have agreed on the use of controlled substance medications to treat your: We want to make sure you know how to manage your new prescription(s)
More informationThe Opioid Crisis in Erin Zerbo, MD Assistant Professor, Department of Psychiatry Rutgers New Jersey Medical School
The Opioid Crisis in 2017 Erin Zerbo, MD Assistant Professor, Department of Psychiatry Rutgers New Jersey Medical School Outline Neurobiology of addiction Epidemiology of the opioid crisis Medication-assisted
More informationSubstance Abuse Protracted Withdrawal
Substance Abuse Protracted Withdrawal Overview 1. Acute and Protracted Withdrawal 2. Withdrawal Potential Kate Speck, PhD, MAC, LADC 3. Recovery Reinforcers 1 2 3 Addiction Addiction is a primary, chronic,
More informationEpidemiologic Data on Opioid Use: Changing Problems
Epidemiologic Data on Opioid Use: Changing Problems 1 Goals 1 To bridge the pain world and addiction world 1. Pain and pain treatment a. Chronic pain affects an estimated 100 million Americans (1/3 of
More informationWelcome to the Opioid Overdose Prevention Project
Welcome to the Opioid Overdose Prevention Project Narcan Training TODAY S OBJECTIVES Define drug addiction Identify symptoms of addiction Treatment options including support for family members How to recognize
More informationModule Two: Pharmacotherapies for Opioid Substitution Treatment
Module Two: Pharmacotherapies for Opioid Substitution Treatment Neurobiology of Addiction Pharmacology of Opioids Methadone Buprenorphine Pharmacokinetics of Methadone & Buprenorphine Opioid effects Intoxication
More informationUnderstanding and Combating the Heroin Epidemic
Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the
More informationMedication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford
Medication Assisted Treatment of an Opioid Use Disorder J. Craig Allen, MD. Medical Director, Rushford Learning objectives At the conclusion of this activity, participants will be able to: Understand
More information5/29/2015. Responding to the Opioid Crisis. Responding to the Opioid Crisis. Objectives
Responding to the Opioid Crisis Responding to the Opioid Crisis David Cohen Ramsen Kasha Objectives Gain knowledge on Current opioid epidemic Historical perspective of opioids The impact of opioids on
More informationOpioid Review and MAT Clinic CDC Guidelines
1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are
More informationPain, Opioids, & Substance Use Disorders
Pain, Opioids, & Substance Use Disorders Kenny Jackson, PharmD, CPE Professor & Senior Associate Dean for Academic Affairs College of Pharmacy Larkin University Miami, Florida Editor-in-Chief Journal of
More informationUnderstanding Addiction
Understanding Addiction How Addiction Hijacks the Brain Addiction involves craving for something intensely, loss of control over its use, and continuing involvement with it despite adverse consequences.
More informationMedical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center
Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers
More informationMANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners, Albany, NY Assistant Professor of Medicine,
More information